KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-cash Items: 2011-2024

Historic Non-cash Items for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $6.3 million.

  • Sarepta Therapeutics' Non-cash Items rose 7041.17% to $425.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $425.0 million, marking a year-over-year increase of 7041.17%. This contributed to the annual value of $6.3 million for FY2024, which is 5.31% up from last year.
  • Sarepta Therapeutics' Non-cash Items amounted to $6.3 million in FY2024, which was up 5.31% from $6.0 million recorded in FY2023.
  • Sarepta Therapeutics' 5-year Non-cash Items high stood at $248.5 million for FY2021, and its period low was $2.0 million during FY2020.
  • Its 3-year average for Non-cash Items is $5.6 million, with a median of $6.0 million in 2023.
  • Per our database at Business Quant, Sarepta Therapeutics' Non-cash Items tumbled by 99.66% in 2020 and then spiked by 12,198.98% in 2021.
  • Over the past 5 years, Sarepta Therapeutics' Non-cash Items (Yearly) stood at $2.0 million in 2020, then surged by 12,198.98% to $248.5 million in 2021, then tumbled by 98.11% to $4.7 million in 2022, then climbed by 26.84% to $6.0 million in 2023, then rose by 5.31% to $6.3 million in 2024.